PRINCETON, N.J. – Sandoz on Tuesday announced an agreement with Upsher-Smith to obtain exclusive U.S. distribution rights for its branded potassium chloride line of products, Klor-Con, and market them under the Sandoz name.
“This agreement expands and strengthens our current relationship with Upsher-Smith and helps us create a leading potassium chloride business,” stated Peter Goldschmidt, president of Sandoz. “With our extensive distribution system, we will be able to improve patient access to these products, while increasing efficiencies and effectiveness.”
Potassium chloride is used to prevent or to treat low levels of potassium in the blood (hypokalemia). Currently, Sandoz distributes generic potassium chloride.
This agreement broadens the Sandoz portfolio of potassium chloride to include branded potassium chloride. Sandoz will distribute the full line of Klor-Con products, including tablet, capsule, powder and effervescent forms.
Sandoz’s and Upsher-Smith’s agreement will be effective July 1, at which point Sandoz plans to begin marketing the full potassium chloride line of products to customers.